These findings reveal the potential of MAL2 for serving as a prognostic biomarker for bladder cancer, which is supported by the findings from previous studies on the association between MAL2 and prognostic conditions of breast, colorectal, and pancreatic cancers.34, 36, 37. This evidence concerns the gene MAL2 and familial pancreatic carcinoma.